Affinage · Plasmodium

SERA3

PBANKA_0304900 · serine repeat antigen 3

Annotated
2026-09-07
11 papers in source corpus 5 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PBANKA_0304900 (SERA3) encodes a papain-domain-containing serine repeat antigen that is expressed, presented at the parasite surface, and proteolytically processed across multiple Plasmodium life-cycle stages, where it functions in host-cell disruption and merozoite egress (PMID:18419771, PMID:41616267). In P. berghei, SERA3 is transcribed and its protein is processed during late liver stages, and it leaks into the hepatocyte cytoplasm during merozoite development, positioning it to contribute to host cell death (PMID:18419771). Conditional mutagenesis established that P. berghei SERA3 is dispensable for hepatocyte invasion and late liver-stage development but is essential for hepatic merozoite egress and the transition to blood-stage infection (PMID:41616267); it also localizes to the surface of ookinetes and sporozoites and is processed at these stages, with SUB1 (subtilisin-like protease) identified as the protease responsible for its maturation (PMID:41616267). Consistent with a non-essential blood-stage role, SERA3 is dispensable for erythrocytic growth in P. falciparum, in contrast to the essential SERA4–6 members of the same locus (PMID:12228245), and is expressed in trophozoite and schizont stages within the coordinately regulated chromosome 2 SERA cluster (PMID:7891737, PMID:12244052). Beyond its processing by SUB1 and its role in hepatic egress, the biochemical activity of the SERA3 papain domain and its downstream targets during host cell disruption have not been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 1994 Low

    Establishing SERA3 as a discrete gene within the chromosome 2 SERA cluster addressed whether it is an independent, stage-regulated transcript rather than part of the adjacent SERA locus.

    Evidence Transcript mapping and stage-specific RT analysis in P. falciparum

    PMID:7891737

    Open questions at the time
    • Transcript mapping only, no protein-level or functional data for SERA3
    • Shared transcriptional control mechanism inferred but not demonstrated
    • No P. berghei ortholog data at this stage
  2. 2002 Medium

    Targeted disruption resolved whether SERA3 is required for asexual blood-stage growth, distinguishing it functionally from its essential paralogs.

    Evidence Gene knockout, antibody reactivity to recombinant protein, RT-PCR/microarray in P. falciparum; indirect immunofluorescence localizing SERA3 in trophozoite/schizont-infected erythrocytes

    PMID:12228245 PMID:12244052

    Open questions at the time
    • Dispensability shown for blood stage only, other life-cycle stages untested
    • Biochemical activity of the protein not addressed
    • Localization method single, no functional consequence linked
  3. 2008 Medium

    Detection of processed SERA3 leaking into the hepatocyte cytoplasm during late liver stages raised the possibility that it participates in host cell disruption during merozoite development.

    Evidence RT-PCR, IFA, Western blot, and a TAP-tagged transgenic line under the endogenous promoter in P. berghei

    PMID:18419771

    Open questions at the time
    • Contribution to host cell death is inferred from localization, not demonstrated functionally
    • Protease responsible for processing not identified in this study
    • Host targets, if any, unknown
  4. 2026 Medium

    Conditional knockout defined a specific and essential role for SERA3 in hepatic merozoite egress, and identified SUB1 as its maturating protease, connecting surface presentation and stage-specific processing to function.

    Evidence Flp/FRT conditional mutagenesis, non-permeabilized surface IFA of ookinetes/sporozoites, and Western blot of proteolytic products in P. berghei

    PMID:41616267

    Open questions at the time
    • Enzymatic activity of the SERA3 papain domain not directly demonstrated
    • Molecular mechanism by which SERA3 drives egress unresolved
    • SUB1 cleavage sites and functional consequence of processing not mapped

Open questions

Synthesis pass · forward-looking unresolved questions
  • The catalytic activity of the SERA3 papain domain, its physiological substrates during hepatic egress and host cell disruption, and the mechanistic link between its surface presentation on ookinetes/sporozoites and its liver-stage function remain unresolved.
  • No demonstrated proteolytic or other enzymatic activity for SERA3
  • No identified substrate or binding partner
  • Role at ookinete/sporozoite surface functionally uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Partners
SUB1 (SUBTILISIN-LIKE PROTEASE; MATURES PBANKA_0304900) [#1]

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2008 PBANKA_0304900 (PbSERA3) is transcribed and its protein is processed during late liver stages in P. berghei; immunofluorescence assays using an antiserum against a non-conserved region of PbSERA3 and a transgenic P. berghei strain expressing TAP-tagged PbSERA3 showed that PbSERA3 leaks into the host cell cytoplasm during merozoite development, where it may contribute to host cell death or activate host cell proteases executing cell death. Processed PbSERA3 was detected by Western blot in cell extracts of schizont-infected cells and merozoite-infected detached hepatic cells. RT-PCR, immunofluorescence assay, Western blot, transgenic parasite expressing TAP-tagged PbSERA3 under endogenous promoter Cellular microbiology Medium 18419771
2026 PBANKA_0304900 (PbSERA3) is essential for hepatic merozoite egress in P. berghei: conditional mutants generated using a yeast-based Flp/FRT system invaded hepatocytes and developed normally in late liver stages but failed to initiate blood-stage infection, demonstrating a required role in liver-stage egress. PbSERA3 was also localized on the surface of ookinetes and sporozoites under non-permeabilized conditions, indicating an extracellular presentation at these stages. PbSERA3 is processed in ookinete and sporozoite stages, yielding two proteolytic products consistent with blood-stage processing. PbSERA3 is identified as a substrate of subtilisin-like protease SUB1, and its proteolytic maturation by SUB1 is proposed as a conserved event required for hepatic egress. Conditional mutagenesis (Flp/FRT system), surface localization by immunofluorescence under non-permeabilized conditions, Western blot of proteolytic processing products mBio Medium 41616267
1994 SERA3 (in P. falciparum) was identified as a distinct gene located 1.8 kb upstream of SERA on chromosome 2; its direction of transcription was mapped relative to other chromosome 2 genetic markers. SERA3 mRNA is expressed in a stage-specific manner (trophozoite and schizont stages) and is coordinately regulated with neighboring SERA locus genes, implicating a shared transcriptional control mechanism. Transcript mapping, RNA sequencing, stage-specific RT analysis Molecular and biochemical parasitology Low 7891737
2002 In P. falciparum, SERA3 (chromosome 2 cluster) was targeted for disruption and found to be dispensable for blood-stage erythrocytic growth, in contrast to SERA4–6 which could not be disrupted. Antibodies from malaria-immune individuals reacted with SERA3 recombinant protein, suggesting expression in at least some parasite populations. Gene disruption by targeted knockout, antibody reactivity assay with recombinant protein, RT-PCR and microarray The Journal of biological chemistry Medium 12228245
2002 In P. falciparum, indirect immunofluorescence microscopy using polyclonal antibodies raised against recombinant N-terminal portions of SERA3–6 detected SERA3 protein expression in trophozoite- and schizont-infected erythrocytes, with similar localization to other SERA family members. Indirect immunofluorescence microscopy with antigen-specific polyclonal antibodies The Journal of biological chemistry Low 12244052

Source papers

Stage 0 corpus · 11 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. The Journal of biological chemistry 137 12228245
2011 Falcipains and other cysteine proteases of malaria parasites. Advances in experimental medicine and biology 116 21660657
2018 A protease cascade regulates release of the human malaria parasite Plasmodium falciparum from host red blood cells. Nature microbiology 100 29459732
2002 Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. The Journal of biological chemistry 83 12244052
2018 Exposure and infection to Plasmodium knowlesi in case study communities in Northern Sabah, Malaysia and Palawan, The Philippines. PLoS neglected tropical diseases 79 29902171
2008 Expression and processing of Plasmodium berghei SERA3 during liver stages. Cellular microbiology 46 18419771
1994 Analysis of stage-specific transcripts of the Plasmodium falciparum serine repeat antigen (SERA) gene and transcription from the SERA locus. Molecular and biochemical parasitology 40 7891737
2023 Genetic diversity and in silico analysis of Plasmodium knowlesi Serine Repeat Antigen (SERA) 3 antigen 2 in Malaysia. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2 37595939
2026 Plasmodium berghei serine repeat antigen 3 (PbSERA3) is required for hepatic merozoite egress. mBio 0 41616267
2026 Bioinformatic analysis of Plasmodium knowlesi Serine Repeat Antigen 3 (SERA3) sequences for antimalarial peptide development. Acta tropica 0 42431567
2025 Therapeutic Targeting and Role of Cysteine Proteases in the Life Cycle of Malaria Parasite. Current medicinal chemistry 0 39185645